TriPath Shareholders Okay Acquisition

Shareholders of Burlington, NC-based TriPath Imaging approved the buyout of its remaining stock by Franklin Lakes, NJ-based Becton Dickinson for $9.25 per share.

In September, Becton Dickinson, a manufacturer of syringes and other medical devices, agreed to buy the remaining 93.5% of TriPath stock it did not already own.

The deal is expected to close on or about Dec. 20. TriPath is a manufacturer of cancer diagnostic tools.

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters